Technegas’ new use in lung transplant imaging

Radiopharmaceutical medical imaging manufacturer Cyclopharm has revealed a possible new use for its Technegas system – for evaluating the progress of lung transplantation. The use is detailed in a US-based study which highlights the clinical utility and operational benefits of the Technegas technology compared to current US ventilation imaging radiopharmaceuticals used in lung transplant evaluation.…

Mesoblast drug gets approval from FDA, but shares drop

Pharmaceutical developer Mesoblast’s Revascor (rexlemestrocel-L) drug for children with hypoplastic left heart syndrome (HLHS) has been granted Regenerative Medicine Advanced Therapy designation by the US Food and Drug Administration (FDA). Earlier this year FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease, acknoeledging that the disrase is…

AstraZeneca orders four more APAS Independence instruments

Drug manufacturer AstraZeneca has ordered four more APAS Independence laboratory instruments from AI microbiology automation manufacturer Clever Culture Systems, formally known as LBT Innovations. The order, worth $3.1 million over seven years, adds to the five APAS instruments already in use by the global pharmaceutical company, where they monitor for bacterial contamination in the company’s…

Manufacturing news briefs — stories you might have missed

Sparc signs distribution agreement for graphene additive Sparc Technologies has executed a non-binding memorandum of understanding (MoU) with CLP Group subsidiary Chin Leong Construction Systems Pte Ltd. The parties will collaborate on marketing Sparc’s ecosparc additive to CLC’s coatings customers in Southeast Asia. Sparc Managing Director Nick O’Loughlin said: “Sparc…hopes to establish this partnership as…

BioCina to scale up novel bioseparation technology

Pharmaceutical and vaccine company BioCina is planning to scale up from laboratory to industrial scale a bioseparation resin technology for the large-scale production of complex medicines made from biopharmaceuticals. Backed by an Australian Economy Accelerator (AEA) grant, Griffith University Institute for Biomedicine and Glycomics Principal Research Leader, Professor Bernd Rehm and his team are leading…

IDT Australia revenue hits new high

Pharmaceutical manufacturer IDT Australia has reported revenue for the quarter ended 30 September up 70 percent on the previous corresponding period to reach a two year high of $5.2 million. The Melbourne company said the results were encouraging and came on top of the it submitting proposals worth $24.7 million and securing $6.8 million in…

Manufacturing news briefs – stories you might have missed

IDT Australia secures Sanofi contract Pharmaceutical development company IDT Australia has secured a follow on contract with pharma giant Sanofi Australia for preclinical formulation, development and manufacture of Sanofi’s messenger RNA (mRNA). The contract, worth up to $4 million, continues the company’s advancement of mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables…

LBT Innovations sells five pharma QC systems

Microbiology automation company LBT Innovations has sold five APAS Independence laboratory instruments to pharmaceutical manufacturer AstraZeneca AB and will provide maintenance and support services over seven years. The total contract value is worth up to $4.1 million depending on the level of services required, and is in addition to the lease of a sixth instrument…

Pfizer invests $150m for microbial resistance

Pfizer Australia has announced a major upgrade to its manufacturing facility in Melbourne to boost production of pharmaceuticals aiming to help address rising levels of antimicrobial resistance. Pfizer has invested $150 million to develop advanced pharmaceutical production facilities for new antimicrobial treatments tackling what is one of the biggest threats to global health. The Victorian…

Baxter Healthcare pharmaceuticals expands in WA

Construction works are complete on a new world-class pharmaceutical compounding centre in Perth which will manufacture lifesaving medicines and help to diversify Western Australia’s economy. The facility will be one of the most technologically advanced compounding centres in Australia and has been supported by the state government’s Investment Attraction Fund. The new Baxter Healthcare facility…